OTCMKTS:VDRM ViaDerma (VDRM) Stock Price, News & Analysis → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free VDRM Stock Alerts 0.0092 0.00 (-1.08%) (As of 05/9/2024 09:03 PM ET) Add Compare Share Share Today's Range0.01▼0.0150-Day Range0.01▼0.0152-Week Range0.01▼0.02Volume1.84 million shsAverage Volume1.58 million shsMarket CapitalizationN/AP/E Ratio0.00Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get ViaDerma alerts: Email Address Ad InvestorPlaceProof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. About ViaDerma Stock (OTCMKTS:VDRM)ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.Read More VDRM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VDRM Stock News HeadlinesMarch 3, 2024 | morningstar.comViaDerma Inc VDRMOctober 24, 2023 | finance.yahoo.comViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & MoreMay 10, 2024 | InvestorPlace (Ad)Proof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…July 6, 2023 | finance.yahoo.comViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & MoreApril 18, 2023 | finance.yahoo.comViaDerma, Inc. (VDRM) Stock Historical Prices & Data - Yahoo FinanceMarch 16, 2023 | finance.yahoo.comViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth ProductMarch 8, 2023 | finance.yahoo.comViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth ProductMarch 2, 2023 | finance.yahoo.comViaDerma Provides an Update on Current & Future Business ActivitiesMay 10, 2024 | InvestorPlace (Ad)Proof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…January 12, 2023 | benzinga.comViaDerma Retains Digital Marketing Leader INTENT SCIENCES to Accelerate Business Growth OnlineSeptember 15, 2022 | finance.yahoo.comViaDerma Successfully Completes Quality Control Testing of its New Vitastem ProductsJune 22, 2022 | finance.yahoo.comViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem ProductsApril 1, 2022 | nz.finance.yahoo.comAvoteo emerges as the first crowdfunding platform without spending moneyApril 1, 2022 | yahoo.comVictoria and David Beckham's UK home 'burgled' while daughter Harper was asleep upstairsApril 1, 2022 | yahoo.comOur existence isn't new, but now transgender people are visible like never beforeMarch 31, 2022 | finance.yahoo.comViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous YearOctober 4, 2021 | finance.yahoo.comViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem UltraAugust 24, 2021 | finance.yahoo.comViaDerma, Inc. Files Amended Financial StatementsAugust 21, 2021 | barrons.comViaDerma Inc.See More Headlines Receive VDRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ViaDerma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:VDRM CUSIPN/A CIKN/A Webviadermalicensing.com Phone(310) 734-6111FaxN/AEmployees75Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.00 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Qing Hua Lin (Age 43)Chief Financial Officer and Director Comp: $4.46kMr. Baotang Zhao (Age 46)Chief Sales Officer Comp: $28.77kMr. Zhang Xie (Age 45)Corporate Secretary and Director Comp: $9.18kDr. Christopher A OtikoFounder, Chief Executive Officer and PresidentDr. Andrew Berman M.D.MPH, Medical Director and Member of Advisory BoardKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors VDRM Stock Analysis - Frequently Asked Questions How have VDRM shares performed in 2024? ViaDerma's stock was trading at 0.01 at the start of the year. Since then, VDRM shares have decreased by 13.2% and is now trading at 0.01. View the best growth stocks for 2024 here. How do I buy shares of ViaDerma? Shares of VDRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VDRM) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViaDerma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
